Date published: 2026-5-30

1-800-457-3801

SCBT Portrait Logo
Seach Input

Olr1591 Inhibitors

Olr1591 inhibitors are a class of chemical compounds specifically designed to target and inhibit the Olr1591 receptor, a member of the olfactory receptor family within the G-protein coupled receptor (GPCR) superfamily. These olfactory receptors, including Olr1591, are essential for the detection and processing of odorant molecules, playing a crucial role in the olfactory system's ability to interpret chemical signals as distinct smells. The Olr1591 receptor operates by binding to specific odorant ligands, triggering a cascade of intracellular signaling events that ultimately lead to the activation of neural pathways responsible for the perception of various odors. Inhibitors of Olr1591 are developed to disrupt this process by binding to the receptor in a way that blocks its interaction with natural ligands, thereby preventing the receptor from initiating its normal signaling pathways. This inhibition can occur through direct competition at the receptor's active site, where the natural odorant molecules would typically bind, or by interacting with allosteric sites, which induce conformational changes that diminish the receptor's functional activity.

The development of Olr1591 inhibitors involves a detailed and systematic approach to optimizing their chemical properties, including binding affinity, selectivity, and stability. Researchers often employ molecular modeling and docking simulations to predict how these inhibitors will interact with the Olr1591 receptor, allowing them to identify the most effective binding sites and design compounds that can efficiently block receptor activity. High-throughput screening of chemical libraries is another essential technique used to identify lead compounds with promising inhibitory effects on Olr1591. Once these lead compounds are identified, they undergo structure-activity relationship (SAR) studies, where their chemical structures are refined to enhance potency, selectivity, and overall stability while minimizing off-target effects. This refinement process may involve modifying the core chemical scaffold or altering functional groups to improve interactions with the receptor. Additionally, considerations such as solubility, lipophilicity, and metabolic stability are carefully evaluated to ensure that these inhibitors can function effectively under physiological conditions. Through this meticulous and strategic development process, Olr1591 inhibitors contribute to a deeper understanding of the molecular mechanisms underlying olfactory receptor function and advance the broader field of GPCR-mediated signal transduction, providing valuable insights into the complex processes that govern sensory perception and olfactory signaling.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Acarbose

56180-94-0sc-203492
sc-203492A
1 g
5 g
$226.00
$605.00
1
(1)

Alpha-glucosidase inhibitor, can indirectly affect cellular carbohydrate metabolism, potentially impacting Olr1591.

Alendronate acid

66376-36-1sc-337520
5 g
$135.00
2
(0)

Bisphosphonate, might modulate bone metabolism pathways indirectly, impacting Olr1591.

Donepezil

120014-06-4sc-279006
10 mg
$74.00
3
(1)

Acetylcholinesterase inhibitor, may influence cholinergic signaling indirectly, impacting Olr1591.

Exendin-4

141758-74-9sc-474611
sc-474611A
500 µg
1 mg
$146.00
$198.00
1
(0)

GLP-1 agonist, can modulate glucose metabolism pathways indirectly, impacting Olr1591.

Finasteride

98319-26-7sc-203954
50 mg
$105.00
3
(1)

5-alpha-reductase inhibitor, might affect androgen signaling indirectly, impacting Olr1591.

Memantine hydrochloride

41100-52-1sc-203628
50 mg
$69.00
4
(2)

NMDA receptor antagonist, can modulate glutamatergic signaling indirectly, impacting Olr1591.

Pioglitazone

111025-46-8sc-202289
sc-202289A
1 mg
5 mg
$55.00
$125.00
13
(1)

Thiazolidinedione, might influence insulin sensitivity pathways indirectly, impacting Olr1591.

Rivaroxaban

366789-02-8sc-208311
2 mg
$158.00
18
(1)

Anticoagulant, could affect blood coagulation pathways indirectly, impacting Olr1591.

Sitagliptin

486460-32-6sc-482298
sc-482298A
sc-482298B
25 mg
100 mg
1 g
$213.00
$473.00
$733.00
10
(0)

DPP-4 inhibitor, may modulate incretin pathways indirectly, impacting Olr1591.